Avidity Biosciences, Inc. (NASDAQ:RNA) currently has 79 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 30 Sep, 2025 | 21,585,984 | 5,400,193 | 33.36% | $940,501,305.00 |
| JANUS HENDERSON GROUP PLC | 30 Sep, 2025 | 14,522,915 | 3,745,598 | 34.75% | $632,808,722.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 13,219,759 | 3,971,457 | 42.94% | $575,984,899.00 |
| RTW INVESTMENTS, LP | 30 Sep, 2025 | 11,372,829 | 1,753,984 | 18.23% | $495,514,160.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 30 Sep, 2025 | 10,065,187 | 815,497 | 8.82% | $438,540,198.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 30 Sep, 2025 | 9,787,417 | -1,021,310 | -9.45% | $426,438.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 9,202,579 | -134,255 | -1.44% | $400,956,371.00 |
| RA CAPITAL MANAGEMENT, L.P. | 30 Sep, 2025 | 8,641,031 | 1,375,000 | 18.92% | $376,489,721.00 |
| Avoro Capital Advisors LLC | 30 Sep, 2025 | 7,645,000 | 595,000 | 8.44% | $333,092,650.00 |
| STATE STREET CORP | 30 Sep, 2025 | 4,888,632 | 687,123 | 16.35% | $212,997,696.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 2,858,049 | 10,084 | 0.35% | $124,547,400.00 |
| Polar Capital Holdings Plc | 30 Sep, 2025 | 2,796,760 | 1,026,373 | 57.97% | $121,854,833.00 |
| Bellevue Group AG | 30 Sep, 2025 | 2,152,862 | 2,152,862 | 0.00% | $93,800,197.00 |
| Casdin Capital, LLC | 30 Sep, 2025 | 1,780,000 | 5,000 | 0.28% | $77,554,600.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 1,732,469 | 586,935 | 51.24% | $75,483,675.00 |
| BANK OF AMERICA CORP /DE/ | 30 Sep, 2025 | 1,725,186 | -114,129 | -6.20% | $75,166,353.00 |
| ORBIMED ADVISORS LLC | 30 Sep, 2025 | 1,638,886 | -174,000 | -9.60% | $71,406,263.00 |
| T. Rowe Price Investment Management, Inc. | 30 Sep, 2025 | 1,401,906 | 588,001 | 72.24% | $61,082.00 |
| Pictet Asset Management Holding SA | 30 Sep, 2025 | 1,338,091 | 370,489 | 38.29% | $58,234,125.00 |
| UBS Group AG | 30 Sep, 2025 | 1,315,859 | 719,305 | 120.58% | $57,331,977.00 |